Eplerenone: will it have a role in the treatment of acute coronary syndromes? - Wikidata - awgldk - TriplyDB

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

http://www.wikidata.org/entity/Q35795323

about

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

http://www.wikidata.org/entity/Q35795323

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

@ast

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

@en

type

label

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

@ast

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

@en

prefLabel

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

@ast

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

@en

P1433

Q35795323-F0566377-BBF9-4360-910E-68D907E92D74

P1476

Q35795323-050278B9-2922-4164-A3F8-FA6EB0E4ED51

P2093

Q35795323-2DCE2DE2-BA7E-44F9-9B34-D630F5F115EB

Q35795323-B648600A-6575-4AB4-A6E8-0457E1E5B7D3

P2860

Q35795323-17C581DE-C07A-41C6-95E8-E74CC6934E0F

Q35795323-43BA3001-47B6-476C-B654-3BAD78A99FBA

Q35795323-4539436C-FE78-458F-9773-7A1C3EB8CE38

Q35795323-784EEBDD-1C0C-4AD8-B201-A0B10BB40296

Q35795323-7ADEB6EE-9B83-4161-A797-9D984664D6F8

Q35795323-D14D7F9A-E420-46FA-94FF-FCD52DDF55DC

Q35795323-E3719448-D243-469C-B751-7C449B405353

Q35795323-EADFFB12-1537-4900-85A9-DF9FDEC3A53F

Q35795323-F776F096-236C-4F79-9543-850ACA1BC95F

P2888

Q35795323-61E616D2-990D-4C0A-A837-44F112FDB008

P304

Q35795323-13A69C45-A102-47EF-9DA4-C8ECBB164C80

P31

Q35795323-87C07610-9E00-47F0-ADE1-C868EDE6FAB2

P356

Q35795323-F2D8EAAC-E73F-4337-9BA5-40D92668D6A2

P433

Q35795323-A02B6400-F1D0-45BA-8E80-E3FC8E4AED67

P478

Q35795323-3C2E0B0A-D02F-4E08-94B2-527C47274194

P50

Q35795323-DE873747-FD83-411E-990F-13D081C60024

P577

Q35795323-AAF835C1-9957-456C-840C-71AC9DB522BB

P698

Q35795323-5945232A-5FEA-47C3-8A87-DE6CE39DF6C8

P356

S11886-004-0073-0

P1433

Current cardiology reports

P1476

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

@en

P2093

David J Meier

http://www.w3.org/2001/XMLSchema#string

Sanjay Rajagopalan

http://www.w3.org/2001/XMLSchema#string

P2860

Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes.

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.

Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.

Current concepts of the pathogenesis of the acute coronary syndromes.

Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy.

Central mineralocorticoid receptor blockade decreases plasma TNF-alpha after coronary artery ligation in rats.

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

P2888

s11886-004-0073-0

P304

259-263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-004-0073-0

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15182600

http://www.w3.org/2001/XMLSchema#string